Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil

Fig. 2

Triggers for prostate biopsy in patients with LUTS/BPE treated with 5ARIs. *A free-text box was provided so participants could give other triggers for prostate biopsy not included in the question. 5ARI, 5-alpha reductase inhibitor; LUTS/BPE, lower urinary tract symptoms/benign prostate enlargement; PSA, prostate-specific antigen. Each country was analyzed independently in this study

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us